Skip to search formSkip to main contentSkip to account menu

RWJ 67657

Known as: RWJ-67657 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

ImidazolesPyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
p38-MAPK inhibition and endotoxin induced tubular dysfunction in men.
BACKGROUND To evaluate the possibility of preventing endotoxin induced renal damage by p38-MAPK inhibition in a human model… 
2003
2003
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2002
2002
Inhibition by a p38MAPK inhibitor (RWJ-67657) of TNFalpha-induced activation of endothelial cells and development of a drug-targeting conjugate selective for activated endothelium.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)